Contents of this document
- Strategic reinvestment¥-4 100 million
- Risk buffer (impact of Middle East risks)¥-1.5 100 million
- Recruitment of top talent¥-1.2 100 million
- Healthcare/AICC¥-1 100 million
- Real estate brokerage/L&P¥-1 100 million
- Foundation for physical AI¥-0.8 100 million
- Strategic reinvestment¥4 100 million
- Risk buffer¥1.5 100 million
- ¥400 million strategic reinvestment in AI and BPaaS
- Building next-generation AI operations
- Planning healthcare, nursing care and healthcare-focused mixed-use residences
- Developing and considering external sales of a proprietary AI agent for real estate sales and brokerage
- Development by KyoHA of SEIMEI, a prototype for validating a fully domestically developed humanoid robot
- Ending ARR disclosure accompanying the expansion into BPaaS
- AICC segment profit margin40 %Year on year against the same period last yearUp from 32.7%
- AUM¥1,552 100 million
- Most recent CAGR in AUM55 %
- Expected improvement in sales efficiency from AI agents30 %
- Expected increase in sales per employee from AI agents20 %
- Number of paying customer companies586 companiesBusinessLH (excluding Medix)Year on year against the same period last yearUp 221 companies from the end of the previous fiscal year
- Average price¥632 thousand/monthBusinessLH (excluding Medix)Year on year against the same period last yearUp 11.9% from ¥565 thousand
- Number of paying customer companies5,279 companiesBusinessPTYear on year against the same period last yearUp 654 companies from the end of the previous fiscal year
- Average price¥62 thousand/monthBusinessPTYear on year against the same period last yearUp 2.0% from ¥61 thousand
- Number of paying customer companies2,426 companiesBusinessLH (including Medix)
- Average price¥162 thousand/monthBusinessLH (including Medix)
- AICCNet Sales¥8,689 millionRevenue_yoy_pct15.5Segment profit¥3,474 millionSegment profit YoY %41
- L&PNet Sales¥26,272 millionRevenue_yoy_pct28Segment profit¥1,196 millionSegment profit YoY %15.1
- LHNet Sales¥5,181 millionRevenue_yoy_pct44.3Segment profit¥1,724 millionSegment profit YoY %87.1
- PTNet Sales¥3,508 millionRevenue_yoy_pct-10.9Segment profit¥1,750 millionSegment profit YoY %13.5
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Fiscal year ending March 2026, full year |
| Net Sales | ¥32,858 million (YoY +23.1%) |
| Operating profit | ¥4,180 million (YoY +34.5%) |
| Ordinary income | ¥3,841 million (YoY +32.3%) |
| Net income | ¥1,840 million (YoY +8.5%) |
| Full-year earnings forecast | Fiscal Period Covered Fiscal year ending March 2027 / Net Sales ¥41,800 million / Operating profit ¥5,230 million / EBITDA ¥6,150 million / Ordinary income ¥4,500 million / Profit attributable to owners of the parent ¥2,830 million / Dividend per share ¥20 / ROE Approximately 12 |
| Self-assessment against the plan | Initial guidance achieved. Operating profit exceeded guidance, LH significantly exceeded guidance, PT fell short of guidance, and L&P achieved guidance |
| Segment results | Segment AICC / Net Sales ¥8,689 million / Revenue_yoy_pct 15.5 / Segment profit ¥3,474 million / Segment profit YoY % 41, Segment L&P / Net Sales ¥26,272 million / Revenue_yoy_pct 28 / Segment profit ¥1,196 million / Segment profit YoY % 15.1, Segment LH / Net Sales ¥5,181 million / Revenue_yoy_pct 44.3 / Segment profit ¥1,724 million / Segment profit YoY % 87.1, Segment PT / Net Sales ¥3,508 million / Revenue_yoy_pct -10.9 / Segment profit ¥1,750 million / Segment profit YoY % 13.5 |
| Breakdown of Factors Affecting the Change | Factors Strategic reinvestment / Amount ¥-4 100 million, Factors Risk buffer (impact of Middle East risks) / Amount ¥-1.5 100 million, Factors Recruitment of top talent / Amount ¥-1.2 100 million, Factors Healthcare/AICC / Amount ¥-1 100 million, Factors Real estate brokerage/L&P / Amount ¥-1 100 million, Factors Foundation for physical AI / Amount ¥-0.8 100 million |
| Key KPIs | Indicator name AICC segment profit margin / Value 40 % / Year on year against the same period last year Up from 32.7%, Indicator name AUM / Value ¥1,552 100 million / Year on year against the same period last year Not disclosed, Indicator name Most recent CAGR in AUM / Value 55 % / Year on year against the same period last year Not disclosed, Indicator name Expected improvement in sales efficiency from AI agents / Value 30 % / Year on year against the same period last year Not disclosed, Indicator name Expected increase in sales per employee from AI agents / Value 20 % / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Business LH (excluding Medix) / Indicator Number of paying customer companies / Value 586 companies / Year on year against the same period last year Up 221 companies from the end of the previous fiscal year, Business LH (excluding Medix) / Indicator Average price / Value ¥632 thousand/month / Year on year against the same period last year Up 11.9% from ¥565 thousand, Business PT / Indicator Number of paying customer companies / Value 5,279 companies / Year on year against the same period last year Up 654 companies from the end of the previous fiscal year, Business PT / Indicator Average price / Value ¥62 thousand/month / Year on year against the same period last year Up 2.0% from ¥61 thousand, Business LH (including Medix) / Indicator Number of paying customer companies / Value 2,426 companies / Year on year against the same period last year Not disclosed, Business LH (including Medix) / Indicator Average price / Value ¥162 thousand/month / Year on year against the same period last year Not disclosed |
| Number of employees | Number of Employees 533 people / As of End of March 2026 / Change during the period Not disclosed / Hiring plan Not disclosed |
| Assumptions Underlying the Business Outlook | Item Strategic reinvestment / Value ¥4 100 million, Item Risk buffer / Value ¥1.5 100 million |
| Risk amount incorporated into the outlook | Amount ¥1.5 100 million / Details Risk that completion of development properties in the L&P business will be delayed due to delays in procuring materials caused by the closure of the Strait of Hormuz |
| Financial targets | ROE Actual results 12.7 % / Year on year against the same period last year -0.4 % / ROE outlook Value Approximately 12 |
| Annual Dividend | Annual dividend per share ¥18 / Interim Not disclosed / End of period Not disclosed / Next-year forecast ¥20 |
| Payout ratio | Approximately 35% of deemed net income for L&P |
| New initiatives | ¥400 million strategic reinvestment in AI and BPaaS, Building next-generation AI operations, Planning healthcare, nursing care and healthcare-focused mixed-use residences, Developing and considering external sales of a proprietary AI agent for real estate sales and brokerage, Development by KyoHA of SEIMEI, a prototype for validating a fully domestically developed humanoid robot, Ending ARR disclosure accompanying the expansion into BPaaS |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended March 2026, AICC benefited from orders focused on profit margins, higher profitability, and productivity gains from proprietary AI tools and other initiatives. At L&P, improvements in rents increased the expected selling prices and profits of properties. For the fiscal year ending March 2027, the Company expects AICC's rollout of industry-specific AI and BPaaS and L&P's stable growth, while making strategic reinvestments in AI talent and next-generation AI operations.